PL2474306T3 - Kompozycja w postaci cząstek stałych i zawierająca ją kompozycja lecznicza - Google Patents

Kompozycja w postaci cząstek stałych i zawierająca ją kompozycja lecznicza

Info

Publication number
PL2474306T3
PL2474306T3 PL10812082T PL10812082T PL2474306T3 PL 2474306 T3 PL2474306 T3 PL 2474306T3 PL 10812082 T PL10812082 T PL 10812082T PL 10812082 T PL10812082 T PL 10812082T PL 2474306 T3 PL2474306 T3 PL 2474306T3
Authority
PL
Poland
Prior art keywords
composition
same
particle
medicinal
medicinal composition
Prior art date
Application number
PL10812082T
Other languages
English (en)
Inventor
Yasuki Kato
Atsushi Ishii
Original Assignee
Nanocarrier Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanocarrier Co., Ltd. filed Critical Nanocarrier Co., Ltd.
Publication of PL2474306T3 publication Critical patent/PL2474306T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
PL10812082T 2009-08-31 2010-08-31 Kompozycja w postaci cząstek stałych i zawierająca ją kompozycja lecznicza PL2474306T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009200681 2009-08-31
EP10812082.5A EP2474306B1 (en) 2009-08-31 2010-08-31 Particle composition and medicinal composition comprising same

Publications (1)

Publication Number Publication Date
PL2474306T3 true PL2474306T3 (pl) 2017-06-30

Family

ID=43628124

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10812082T PL2474306T3 (pl) 2009-08-31 2010-08-31 Kompozycja w postaci cząstek stałych i zawierająca ją kompozycja lecznicza

Country Status (13)

Country Link
US (1) US9415059B2 (pl)
EP (2) EP2474306B1 (pl)
JP (1) JP4912510B2 (pl)
KR (1) KR101689787B1 (pl)
CN (2) CN104758254B (pl)
AU (1) AU2010287391B2 (pl)
CA (1) CA2768651C (pl)
DK (1) DK2474306T3 (pl)
ES (1) ES2614615T3 (pl)
HU (1) HUE031793T2 (pl)
PL (1) PL2474306T3 (pl)
PT (1) PT2474306T (pl)
WO (1) WO2011025036A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI568453B (zh) * 2011-11-22 2017-02-01 原創生醫股份有限公司 具有螯合型複合微胞之藥物載體及其應用
US20180071199A1 (en) * 2015-02-27 2018-03-15 Nanocarrier Co., Ltd. Polymer treatment agent
CN107249565A (zh) * 2015-02-27 2017-10-13 那野伽利阿株式会社 聚合物微团载体组合物和聚合物微团组合物
US20180264119A1 (en) * 2015-09-16 2018-09-20 Shimadzu Corporation Nanoparticles and method for producing same
JP2019060866A (ja) * 2017-09-22 2019-04-18 旭化成ファーマ株式会社 液状医薬組成物の体内動態を予測する方法
CN109134778B (zh) * 2018-08-16 2021-03-09 西南民族大学 电荷翻转型聚合物胶束、载药胶束及其制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR940003548U (ko) * 1992-08-14 1994-02-21 김형술 세탁물 건조기
TW520297B (en) 1996-10-11 2003-02-11 Sequus Pharm Inc Fusogenic liposome composition and method
ATE255882T1 (de) 1997-06-23 2003-12-15 Sequus Pharm Inc Liposomen-umschlossene polynukleotidzusammensetzung sowie verfahren
SE9702776D0 (sv) 1997-07-22 1997-07-22 Pharmacia & Upjohn Ab Method of preparing pharmaceutical compositions
US6919372B1 (en) 1997-12-26 2005-07-19 Yamanouchi Pharmaceutical Co., Ltd. Sustained release pharmaceutical compositions
US6383811B2 (en) 1997-12-30 2002-05-07 Mirus Corporation Polyampholytes for delivering polyions to a cell
DE19954843C2 (de) 1999-11-09 2003-11-20 Novosom Ag Verfahren zur Verkapselung von Proteinen oder Peptiden in Liposomen, mit dem Verfahren hergestellte Liposomen und deren Verwendung
JP4659937B2 (ja) * 1999-11-19 2011-03-30 ナノキャリア株式会社 コア−シェル構造のポリイオンコンプレックスミセル
GB0009773D0 (en) * 2000-04-19 2000-06-07 Univ Cardiff Particulate composition
EP1415648B1 (en) * 2001-07-13 2006-11-22 NanoCarrier Co., Ltd. Lyophilizing composition of drug-encapsulating polymer micelle and method for preparation thereof
US20030191081A1 (en) 2001-12-28 2003-10-09 Pierre Lemieux Pharmaceutical compositions and methods of use thereof comprising polyanionic polymers and amphiphilic block copolymers to improve gene expression
US20060099265A1 (en) * 2003-03-20 2006-05-11 Kazuhisa Shimizu Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer
ES2559828T3 (es) * 2003-07-16 2016-02-16 Protiva Biotherapeutics Inc. ARN de interferencia encapsulado en lípidos
NZ592917A (en) * 2003-09-15 2012-12-21 Protiva Biotherapeutics Inc Stable polyethyleneglycol (PEG) dialkyloxypropyl (DAA) lipid conjugates
KR20060132927A (ko) 2004-03-10 2006-12-22 교와 핫꼬 고교 가부시끼가이샤 복합 입자 및 피복 복합 입자
JP2008504827A (ja) 2004-07-02 2008-02-21 プロチバ バイオセラピューティクス インコーポレイティッド 免疫賦活性ｓｉＲＮＡ分子およびその使用方法
WO2006007712A1 (en) 2004-07-19 2006-01-26 Protiva Biotherapeutics, Inc. Methods comprising polyethylene glycol-lipid conjugates for delivery of therapeutic agents
JP2006056864A (ja) * 2004-08-17 2006-03-02 Yukio Nagasaki 静電結合型ポリマー修飾リポソーム薬物キャリアの供給とその使用
JP5061349B2 (ja) * 2005-02-10 2012-10-31 国立大学法人 東京大学 ポリカチオン荷電性ポリマー及び核酸のキャリヤーとしての使用
US20090258079A1 (en) 2005-05-10 2009-10-15 Ryoichi Katakai Biocompatible Block Copolymer, Use Thereof and Manufacturing Method Thereof
JPWO2007136134A1 (ja) * 2006-05-23 2009-10-01 ナノキャリア株式会社 疎水性薬物内包ポリマーミセルの製造方法
CN101489574A (zh) 2006-07-18 2009-07-22 那野伽利阿株式会社 内包生理活性多肽或蛋白质的高分子聚合物胶束及其制造方法
CA2927045A1 (en) * 2006-10-03 2008-04-10 Muthiah Manoharan Lipid containing formulations
CA2666697C (en) 2006-10-19 2015-03-31 Nanocarrier Co., Ltd. Block copolymer for drug conjugates and pharmaceutical composition
US8241647B2 (en) 2007-05-17 2012-08-14 Waseda University Amphiphilic molecule, molecular assembly comprising the amphiphilic molecule, and use of the molecular assembly
US20110268772A1 (en) * 2008-12-26 2011-11-03 Samyang Corporation Pharmaceutical composition containing an anionic drug and a production method thereof

Also Published As

Publication number Publication date
US20120107377A1 (en) 2012-05-03
EP2474306B1 (en) 2016-11-09
DK2474306T3 (en) 2017-02-06
EP2474306A4 (en) 2013-11-27
CA2768651A1 (en) 2011-03-03
KR101689787B1 (ko) 2016-12-26
CA2768651C (en) 2017-05-16
WO2011025036A1 (ja) 2011-03-03
CN102481255A (zh) 2012-05-30
CN104758254A (zh) 2015-07-08
EP2474306A1 (en) 2012-07-11
HUE031793T2 (en) 2017-07-28
AU2010287391B2 (en) 2016-02-25
PT2474306T (pt) 2016-12-07
JP4912510B2 (ja) 2012-04-11
AU2010287391A1 (en) 2012-02-16
JPWO2011025036A1 (ja) 2013-01-31
ES2614615T3 (es) 2017-06-01
KR20120083280A (ko) 2012-07-25
EP3150194A1 (en) 2017-04-05
US9415059B2 (en) 2016-08-16
CN102481255B (zh) 2015-04-22
CN104758254B (zh) 2018-10-30

Similar Documents

Publication Publication Date Title
IL253870B (en) Certain amino-pyrimidines and pharmaceutical preparations containing them
IL217912A (en) History of 5-Amino-1-Benzimidazole-Pyrazole and Pharmaceutical Preparations Containing It
EP2486918A4 (en) PHARMACEUTICAL COMPOSITION WITH BOTH IMMEDIATE AND DELAYED RELEASE
ZA201200722B (en) Pharmaceutical composition and administrations thereof
EP2515946A4 (en) NANOCONJUGATES AND COMPOSITIONS OF NANOCONJUGATES
EP2547373A4 (en) NANOTUBES AND ASSOCIATED COMPOSITIONS
EP2474522A4 (en) AGOMÉLATINE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
EP2471799A4 (en) RARE EARTH COMPLEX AND ITS USES
PT2605757E (pt) Formulações à base de nalbufina e suas utilizações
HK1166633A1 (en) Indenone derivative and pharmaceutical composition comprising same
PT2251006T (pt) Micropartículas e suas composições farmacêuticas
ZA201200079B (en) Pharmaceutical compositions and solid forms
EP2474306A4 (en) PARTICULATE COMPOSITION AND DRUG COMPOSITION COMPRISING THE SAME
GB0902429D0 (en) Compositions and their use
EP2445895A4 (en) DITHIOCTATE OF PIPERAZINE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
GB0908174D0 (en) Steroid containing composition and uses thereof
GB0902648D0 (en) Pharmaceutical compounds and compositions
ZA201200260B (en) Polyphenylsulphone-polytetrafluroethylene compositions and use thereof
IL219018A (en) Radzolid Pharmaceuticals and Uses
PL2415463T3 (pl) Kompozycja lecznicza w postaci cząstek stałych
IL217137A0 (en) Medicinal and herbal composition and uses thereof
GB0908317D0 (en) Pharmaceutical compounds and compositions
GB0909792D0 (en) Composition and uses thereof
GB201020268D0 (en) Composition and uses
GB0902651D0 (en) Pharmaceutical compounds and compositions